USANA Health Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Operating Leases (Tables)

Operating Leases (Tables)

6 Months Ended

Jun. 29, 2019

Operating Leases [Abstract]

Summary Of Lease Assets And Lease Liabilities In The Balance Sheet



				As of
Leases		Classification		June 29, 2019
Assets
ROU operating lease assets, net		Other assets		$	25,325
Total ROU assets				$	25,325

Liabilities
Current:
Operating lease liabilities		Other current liabilities		$	6,782
Non-current:
Operating lease liabilities		Other long-term liabilities		$	12,650
Total lease liabilities				$	19,432

Supplemental Lease Information



		Quarter Ended			Six Months Ended
		June 29,			June 29,
		2019			2019
Lease cost
Operating lease cost		$	2,328		$	4,494
Total lease cost		$	2,328		$	4,494



					Six Months Ended
					June 29,
					2019
Other information
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases					$	4,215
ROU assets obtained in exchange for new operating lease liabilities					$	3,305
Weighted-average remaining lease term—operating leases						4.00 yrs.
Weighted-average discount rate—operating leases						3.73%

Maturity Analysis For Operating Lease Liabilities



Year ending
Remainder of 2019				$	3,953
2020					6,661
2021					4,204
2022					1,836
2023					1,584
Thereafter					2,618
				$	20,856
Less: imputed interest				$	(1,424)
Present value				$	19,432

Schedule Of Future Commitments Under Operating Leases



Year ending
2019	$	9,155
2020		6,146
2021		3,825
2022		1,962
2023		1,464
Thereafter		2,514
	$	25,066